CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
We are very excited to launch our new website! Please take a few moments to click around and explore...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...